## EMR: Emerson Electric Company - XLI: Industrials

### Executive Summary

No thesis match: MRS_10 -0.6% below STRENGTH zone (3.0-6.0%); PEG 1.40 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($125.20)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 8, Bearish: 0)

**1. Emerson Electric (EMR): Evaluating Valuation as Firm Expands Role in Texas Solar Infrastructure**
- Source: Simply Wall Street | 20251202T103509 | Bullish | Relevance: 99%
- Emerson Electric (EMR) is expanding its presence in renewable energy infrastructure through its Ovation Green platform, recently chosen for Mitsuiâ€™s 110MW Three W Solar site in Texas. Despite a modest 1-year return, Emerson shows strong long-term growth and is considered undervalued by analysts, with a consensus fair value of $150.84 against a current price of $131.94, driven by expectations of rising revenues and margin gains. However, its P/E ratio is slightly above the US Electrical industry average, suggesting potential valuation risks if market optimism wanes.

**2. New York State Common Retirement Fund Sells 15,500 Shares of Emerson Electric Co. $EMR**
- Source: MarketBeat | 20251201T120431 | Somewhat-Bullish | Relevance: 99%
- The New York State Common Retirement Fund decreased its stake in Emerson Electric Co. by 1.8%, selling 15,500 shares. Despite this, other institutions like Schroder Investment Management Group and Norges Bank significantly increased their holdings, with institutional investors now owning 74.30% of the company's stock. Emerson Electric also announced an increased quarterly dividend and a share repurchase program, while analysts maintain a "Moderate Buy" rating with a consensus price target of $148.13.

**3. Emerson (EMR) Outlines 2028 Financial Targets and $10 Billion Shareholder Return Plan**
- Source: Yahoo Finance | 20251202T130600 | Bullish | Relevance: 99%
- Emerson Electric Co. (EMR) has unveiled its financial targets through 2028, focusing on "engineering the autonomous future," and announced a plan to return $10 billion to shareholders via share repurchases and dividend increases. The company targets 4%-7% organic sales growth, 40% incremental margins, 10% adjusted EPS growth, and an 18%-20% free cash flow margin. Emerson also recently increased its quarterly dividend by 5.2% to $0.555 per share, marking 69 consecutive years of dividend growth, and authorized the repurchase of up to 50 million shares of common stock.

**4. Emerson Electric Co. $EMR Shares Bought by Smith Moore & CO.**
- Source: MarketBeat | 20251202T121746 | Bullish | Relevance: 99%
- Smith Moore & CO. increased its holdings in Emerson Electric Co. (EMR) by 8.5% in the second quarter, bringing its total to 26,892 shares valued at $3.59 million. Other institutional investors also adjusted their positions, with institutional ownership now at approximately 74.3% of the stock. Analysts have a "Moderate Buy" consensus rating for EMR with an average target price of $148.13, and the company recently raised its quarterly dividend to $0.555 per share and approved a share repurchase plan.

**5. Quadrant Capital Group LLC Has $1.97 Million Stock Position in Emerson Electric Co. $EMR**
- Source: MarketBeat | 20251130T112342 | Bullish | Relevance: 98%
- Quadrant Capital Group LLC increased its stake in Emerson Electric Co. (NYSE:EMR) by 29.4% in the second quarter, bringing its total holding to 14,740 shares valued at $1.97 million. Institutional investors collectively own 74.30% of Emerson Electric's stock, and analysts have an average "Moderate Buy" rating with a target price of $148.13. Emerson Electric also recently increased its quarterly dividend to $0.555 per share, yielding 1.7%.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Jefferies | $145 | $0 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Jefferies | down | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 10 ($0.00M) |
| Sells | 23 ($17.20M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 42.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 9.7% (+0.4%)
- JPMORGAN CHASE & CO: 7.6% (+240.7%)
- Blackrock Inc.: 7.1% (+3.1%)
- State Street Corpora: 4.8% (-0.4%)
- Bank of America Corp: 3.0% (-12.9%)

### Key Risks

1. Heavy insider selling: $17M sold (23 transactions in 90 days).
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.40 suggests fair value with growth premium. Insider selling cluster ($17.2M in 90 days), potential headwind. Institutional flow bullish (4 buying vs 6 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $77.1B |
| Beta | 1.25 |
| 52W Range | $90.06 - $150.27 |
| Short Interest | 2.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.40 |
| Forward P/E | 18.6 |
| Current P/E | 20.4 |
| YoY Growth | 9.6% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 0.8% to -0.6% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 3.6pp (needs >3.0% for momentum thesis). Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (0.51), confirming momentum. RSI neutral at 52.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.64% (CS: 59) | Neutral |
| RSI_14 | 52.4 | Neutral |
| MACD Histogram | 0.51 | Bullish |
| vs SMA20 | 1.014x | Above |
| vs SMA50 | 1.004x | Above |
| vs SMA200 | 1.051x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $131.84
- **Stop Loss:** $125.20 (5.0% risk)
- **Target:** $138.48 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 75
- **Position Value:** $9,888.00
- **Portfolio %:** 9.89%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-04 (Est: $1.42)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.62 | $1.62 | +0.3% |
| 2025Q2 | $1.51 | $1.52 | +0.7% |
| 2025Q1 | $1.41 | $1.48 | +4.6% |
| 2024Q4 | $1.28 | $1.38 | +8.0% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*